The Latest
-
Amwell expects lower revenue in 2026
The health technology company has divested assets and refocused on its core offering, resulting in a smaller top line, executives said on an earnings call Thursday.
-
HHS elevates officials into Kennedy’s inner circle in advance of midterms
The HHS secretary has four new senior advisors to help him “move faster and go further” on his Make America Healthy Again agenda. The appointments preempt the GOP’s midterm messaging push.
-
TEFCA, Health Tech Ecosystem are complementary data sharing efforts: officials
The Health Technology Ecosystem, which the HHS and CMS launched last summer, could accelerate advancements in data exchange and isn’t in competition with the ASTP's own interoperability project, officials said.
-
Lowering drug costs is on Republicans’ minds. Democrats say GOP policies don’t help.
Lawmakers on both sides of the aisle decried the nation’s high drug costs during a House subcommittee hearing last week. Democrats argued Medicaid cuts and lapsed ACA subsidies are worsening the problem.
-
Q&A
How the generative AI boom changes healthcare cybersecurity
Taylor Lehmann, a security executive at Google Cloud, discusses cyber risks in AI systems and how healthcare organizations should prepare.
-
Top healthcare conferences to attend in 2026
These are the events healthcare leaders should plan for this year, covering topics like digital health, rural care and financial management.
Updated Jan. 30, 2026 -
Tenet expects $250M hit from loss of ACA subsidies this year
Still, the for-profit hospital operator’s projected loss is less than some of its peers, and Tenet said it expected to grow its earnings in 2026.
-
Humana could end 2026 as the largest Medicare Advantage insurer
Humana is nabbing MA members while UnitedHealthcare sheds lives. That leaves the companies neck and neck when it comes to MA enrollment, though Humana’s growth is a gamble at a time of elevated medical spending.
-
Kaiser reaches settlement with DOL over alleged mental healthcare access failures
The Department of Labor alleged Kaiser didn’t offer adequate provider networks and used patient questionnaires to prevent members from receiving care.
-
CDC moves to cut $600M in grants to Democrat-led states
The cut grants, which were viewed by Healthcare Dive, fund a wide swath of areas including workforce initiatives, STI prevention measures, health equity proposals and others in California, Colorado, Illinois and Minnesota.
-
House Republicans subpoena 8 health insurers over ACA fraud
The subpoenas request additional documents and information from CVS, Centene, Elevance and more, and suggest House Republicans are considering legislation to combat what they view as rampant fraud in the ACA exchanges.
-
CVS holds 2026 guidance steady as turnaround plan bears fruit
The healthcare giant outperformed to close out 2025, and expects its finances to improve further this year. Still, proposed Medicare Advantage rates could be an issue moving forward.
-
FDA refuses to review Moderna’s mRNA flu vaccine
Moderna claimed that the decision, issued by top vaccine regulator Vinay Prasad, was “inconsistent” with prior FDA communications and went against the regulator’s established guidance for flu shots.
-
Cigna to lay off 2,000 workers worldwide
Cigna’s layoffs follow other recent downsizing announcements from health insurers looking to cut costs during an era of heightened medical spending.
-
Centene swings to loss but predicts stabilization in 2026
Centene outperformed in the fourth quarter, while predicting earnings growth in 2026 — a rarity among managed care companies’ generally dour outlooks.
-
CMS proposes sweeping ACA exchange rule
The CMS said the regulation should remove barriers to more affordable health plans like catastrophic coverage, as enrollment on the exchanges falls following the expiration of stronger financial assistance.
-
Kaiser Permanente strike expands as pharmacy, lab workers walk out
More than 3,000 pharmacy technicians, pharmacy assistants and clinical laboratory professionals joined the strike, which entered its third week on Monday.
-
Baxter cuts roughly 90 jobs at IV solutions plant that recovered from Hurricane Helene
Baxter’s North Cove site made about 60% of the U.S. supply of IV fluids. Hospital demand for IV solutions in the U.S. is lower than before Hurricane Helene, the company said.
-
Kaiser increased its operating income in 2025, despite rising expenses
The integrated healthcare conglomerate nearly tripled its operating income last year compared to 2024.
-
Hims cancels plans to sell compounded GLP-1 pill after FDA backlash
Following escalating legal threats from federal regulators regarding plans to sell an unapproved form of Novo Nordisk’s Wegovy pill, Hims said it “decided to stop offering access” to the treatment.
Updated Feb. 9, 2026 -
Healthcare industry outlook for 2026: Providers, insurers, IT companies look to stability
Companies are hoping to reshore finances and double down on efficiency initiatives this year as several policy sea changes threaten to upend the industry.
-
HHS scraps 340B rebate pilot in win for hospitals
The Trump administration agreed to drop a controversial pilot that would have allowed drugmakers to give post-sales rebates on some drugs instead of upfront discounts.
-
White House’s online service for drug sales debuts with limited impact on prices
Select products from Pfizer, Eli Lilly and others will be sold at a discount, although the lower costs won’t be felt by many Americans whose medications are covered by insurance.
-
Deep Dive
Health insurers brace for impact in 2026
Profits will start to tick up after reaching trough levels. Washington will play nice. M&A and AI adoption will accelerate. We asked experts to look into their crystal balls on what the coming year means for a beleaguered industry.
-
Cigna posts ‘low-drama’ fourth quarter following major FTC settlement
Cigna is hoping the settlement it reached with regulators paired with recent legislation will mollify calls to reform PBMs — without affecting Express Scripts’ profitability.